A First Time In Human Study To Assess The Compound GSK615915

Summary

GSK615915A is being developed as a novel surfactant for use in the formulation of GSK's future generation of Metered Dose Inhalers (MDIs). A surfactant in a MDI would provide a more stable drug suspension, this in turn will produce a consistent dose of drug being delivered with each puff.

Timeline

Start

2005-11-23

Primary completion

2006-07-03

Completion

2006-07-03

Drugs

Indications